SREBF2 and metabolic dysfunction-associated steatohepatitis: In the SREBP2 nuclear translocation enhanced NASH model, Western blot analysis showed a synergistic decrease in AMPK Thr172 phosphorylation level and MST1 expression (Figs. 1e, g, 4a).